Navigation Links
China Yingxia International, Inc. Appoints Chief Financial Officer
Date:6/16/2008

HARBIN, China, June 16 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplements, and personal care products in the People's Republic of China ("PRC"), today announced the appointment of Mr. Ren Hu as its new chief financial officer effective June 11, 2008.

Mr. Hu assumed responsibility as the Company's CFO on June 11, 2008 and will report directly to Ms. Yingxia Jiao, CEO of China Yingxia. Mr. Hu will be responsible for overseeing the Company's overall financial planning, control and reporting activities, SEC compliance, audit and investor relations. Mr. Hu has over 25 years of experience in business and finance, with expertise on Wall Street. Prior to joining China Yingxia, Mr. Hu worked as a vice president of finance at China Kangtai Cactus Bio-Tech, Inc. (OTCBB: CKGT), from June 2006 to June 2008, where he was in charge of North American operations, namely timely filing of SEC reports, investor relations, and capital raising. In addition, Mr. Hu worked as the vice president for Phoenix Forest, LLC., the US investment banking arm of Lin Feng Group, in 2005, executing a reverse merger transaction for a China based power plant, and as the president for China Finance, Inc. (OTCBB: CHFI) in 2004, overseeing investor relations.

Mr. Hu also has extensive brokerage house and hedge fund management and trading experiences and has/had FINRA (formerly NASD) securities licenses S7, S55 and S63. Mr. Hu received his MBA from London Business School in 1989 and MS in finance from Florida International University in 1994. He is currently an ABD (all-but-dissertation doctoral candidate) in international business at Rutgers University.

"We are very pleased to have Mr. Hu join China Yingxia as our chief financial officer," said Ms. Yingxia Jiao, CEO of China Yingxia. "Mr. Hu's prior experience working at one of our peer company's and a Chinahybrid, helps him in moving China Yingxia forward as well as helps our firm in its financial oversight and reporting capabilities," added Ms. Jiao.

"I am excited to join China Yingxia and look forward to working closely with Ms. Jiao and the rest of the team in accomplishing the Company's financial goals," commented Mr. Hu. "In addition, I look forward to working closely with the investment community in communicating the Company's financials."

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, cactus-based herbal supplements, personal care products, Nestle products, and organic rice products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' vexpect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc

Tel: +1-201-887-0415

Email: arenhu@gmail.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Website: http://www.ccgir.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company
2. China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
3. AmeriCares Establishes Field Hospital in China
4. China Sky One Medical, Inc. Announces Guidance for Second Quarter and Full Year 2008
5. AmeriCares Purchases BLU-MED Portable Hospital for China Earthquake Relief
6. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
7. China Sky One Medical, Inc. Receives SFDA Approval for Five Patches
8. Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs
9. Free Wheelchair Mission to Distribute 4,400 Wheelchairs to China Earthquake Victims
10. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
11. China Sky One Medical, Inc. Donates RMB 1.1 Million in Medicine for Earthquake Disaster Relief Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Indianapolis, IN (PRWEB) , ... February 08, 2016 ... ... serving the Indianapolis, IN metro area, has selected the latest beneficiary of their ... nonprofit organization dedicated to preventing bullying in area schools. Donations are now being ...
(Date:2/8/2016)... San Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... helped raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently ... who also was the American Cancer Society’s 2015 CEO of the Year , ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying “rub some ... to Perry A~, author of “Calcium Bentonite Clay” the health benefits of integrating clay ... and detoxifying the body. , A former motivational speaker, Perry A~ has since dedicated ...
(Date:2/8/2016)... ... February 08, 2016 , ... FileHold's document management ... DocuSyst provides a cloud hosted environment for FileHold software that is pay per ... 3rd party applications using the FileHold web services API. DocuSyst also advises clients ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... greater than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth ... ”It is time to make a change in public health,” states Carole Baggerly, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, Inc. ... genome editing, announced that the U.S. Food and ... New Drug (IND) application for SB-318, a single ... for Mucopolysaccharidosis Type I (MPS I). The SB-318 ... to initiate a Phase 1/2 clinical study (SB-318-1502) ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: